David Abrams
TEVA icon

David Abrams’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

David Abrams’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,996,836
Closed -$62.6M – 14
2023
Q4 		$62.6M Sell
5,996,836
-1,969,597
-25% -$18.4M 1.95% 11
2023
Q3 		$81.3M Hold
7,966,433
– – 2.68% 11
2023
Q2 		$60M Hold
7,966,433
– – 1.73% 13
2023
Q1 		$70.5M Sell
7,966,433
-7,966,432
-50% -$78.8M 2.23% 12
2022
Q4 		$145M Sell
15,932,865
-7,966,431
-33% -$69.5M 5.18% 10
2022
Q3 		$193M Sell
23,899,296
-147,060
-0.6% -$1.3M 5.56% 10
2022
Q2 		$181M Hold
24,046,356
– – 4.86% 11
2022
Q1 		$226M Hold
24,046,356
– – 5.27% 12
2021
Q4 		$193M Hold
24,046,356
– – 4.23% 12
2021
Q3 		$234M Hold
24,046,356
– – 5.11% 9
2021
Q2 		$238M Hold
24,046,356
– – 5.29% 9
2021
Q1 		$277M Hold
24,046,356
– – 6.25% 7
2020
Q4 		$232M Hold
24,046,356
– – 6.54% 8
2020
Q3 		$217M Hold
24,046,356
– – 6.85% 6
2020
Q2 		$296M Hold
24,046,356
– – 9.58% 2
2020
Q1 		$216M Hold
24,046,356
– – 8.5% 3
2019
Q4 		$236M Hold
24,046,356
– – 7.32% 5
2019
Q3 		$165M Buy
24,046,356
+6,000,000
+33% +$46M 4.63% 12
2019
Q2 		$167M Hold
18,046,356
– – 4.52% 10
2019
Q1 		$283M Sell
18,046,356
-476,016
-3% -$8.39M 7.95% 5
2018
Q4 		$286M Sell
18,522,372
-1,000,000
-5% -$20.5M 11.8% 3
2018
Q3 		$421M Sell
19,522,372
-220,751
-1% -$5.12M 11.12% 1
2018
Q2 		$480M Hold
19,743,123
– – 13.36% 1
2018
Q1 		$337M Hold
19,743,123
– – 10.58% 2
2017
Q4 		$374M Sell
19,743,123
-1,880,763
-9% -$28.3M 12.6% 2
2017
Q3 		$381M Buy
+21,623,886
New +$487M 14.85% 2
2013
Q3 		– Sell
-2,561,269
Closed -$100M – 13
2013
Q2 		$100M Buy
+2,561,269
New +$100M 5.81% 6

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ion Asset Management
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Slate Path Capital
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

David Abrams's TEVA Position: Q1 2024 in Review

David Abrams sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2024, closing a stake of 5,996,836 shares — an estimated $62.6M sold.

David Abrams first reported a position in TEVA in Q2 2013 and held it in 27 quarters. The position peaked at $480M in Q2 2018. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • David Abrams reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2024 after selling out during the quarter.
  • David Abrams sold 5,996,836 Teva Pharmaceutical Industries Limited shares in Q1 2024, an estimated $62.6M.
  • David Abrams first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 27 quarters.
  • David Abrams's Teva Pharmaceutical Industries Limited position peaked at $480M in Q2 2018.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2024.

Based on Abrams Capital Management's 13F filing for Q1 2024, filed 14 May 2024.